000 01557 a2200409 4500
005 20250514004924.0
264 0 _c20010830
008 200108s 0 0 eng d
022 _a0270-4137
024 7 _a10.1002/pros.1097
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRekasi, Z
245 0 0 _aRegulation of prostate-specific antigen (PSA) gene expression and release in LNCaP prostate cancer by antagonists of growth hormone-releasing hormone and vasoactive intestinal peptide.
_h[electronic resource]
260 _bThe Prostate
_cAug 2001
300 _a188-99 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
650 0 4 _aAndrogens
_xpharmacology
650 0 4 _aAnimals
650 0 4 _aCyclic AMP
_xbiosynthesis
650 0 4 _aDisease Progression
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aGene Expression Regulation, Neoplastic
650 0 4 _aGrowth Hormone-Releasing Hormone
_xantagonists & inhibitors
650 0 4 _aMale
650 0 4 _aMice
650 0 4 _aProstate-Specific Antigen
_xbiosynthesis
650 0 4 _aProstatic Neoplasms
_xgenetics
650 0 4 _aTumor Cells, Cultured
650 0 4 _aVasoactive Intestinal Peptide
_xpharmacology
700 1 _aSchally, A V
700 1 _aPlonowski, A
700 1 _aCzompoly, T
700 1 _aCsernus, B
700 1 _aVarga, J L
773 0 _tThe Prostate
_gvol. 48
_gno. 3
_gp. 188-99
856 4 0 _uhttps://doi.org/10.1002/pros.1097
_zAvailable from publisher's website
999 _c11419729
_d11419729